scispace - formally typeset
J

Jakob Linseisen

Researcher at German Cancer Research Center

Publications -  295
Citations -  25283

Jakob Linseisen is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Population. The author has an hindex of 84, co-authored 251 publications receiving 23040 citations. Previous affiliations of Jakob Linseisen include Helmholtz Zentrum München.

Papers
More filters
Journal ArticleDOI

IGF-1, IGFBP-1 and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: Findings from the breast and prostate cancer cohort consortium (BPC3)

TL;DR: The impact of genetic variation in IGF1 and IGFBP3 on circulating IGF levels does not appear to substantially influence breast cancer risk substantially among primarily Caucasian postmenopausal women.
Journal ArticleDOI

Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

TL;DR: It is suggested that metabolic abnormalities and obesity may act synergistically to increase endometrial cancer risk.
Journal ArticleDOI

Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition

TL;DR: There was evidence that the RR of pancreatic cancer was associated with increased height and there was a nonsignificant decreased risk with total physical activity, but future studies should consider including measurements of waist and hip circumference, to further investigate the relationship between central adiposity and the risk of Pancic cancer.
Journal ArticleDOI

Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study

TL;DR: The results of this first European cohort study support data from case-control studies of a positive association between HCA intake and colorectal adenoma risk.